WallStSmart
CGEM

Cullinan Oncology LLC

NASDAQ: CGEM · HEALTHCARE · BIOTECHNOLOGY

$12.85
+0.31% today

Updated 2026-04-29

Market cap
$837.68M
P/E ratio
P/S ratio
25.86x
EPS (TTM)
$-3.36
Dividend yield
52W range
$6 – $17
Volume
0.8M

Cullinan Oncology LLC (CGEM) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+2.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-5.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-2.5%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-3.4%
2026-03-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-05$-0.77+11.9%$16.30$15.74-3.4%
2025-11-06$-0.77+18.9%$7.31$7.19-1.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.87$-0.77+11.9%
2025-09-30$-0.95$-0.77+18.9%
2025-06-30$-0.82$-1.19-45.1%
2025-03-31$-0.99$-0.74+25.3%
2024-12-31$-0.74$-0.73+1.7%
2024-09-30$-0.81$-0.69+14.8%
2024-06-30$-0.73$-0.75-2.7%
2024-03-31$-0.99$-0.86+13.1%
2023-12-31$-0.96$-0.54+43.7%
2023-09-30$-0.92$-0.91+1.1%
2023-06-30$-0.97$-0.82+15.5%
2023-03-31$-0.98$-1.42-44.9%
2022-12-31$-0.66$-0.59+10.6%

Frequently asked questions

Has Cullinan Oncology LLC beaten earnings estimates?
Cullinan Oncology LLC has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +2.7% over the last 4 quarters.
How does CGEM stock react to earnings?
CGEM stock has moved an average of -2.5% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.